You just read:

Eisai to Present LENVIMA® (lenvatinib) and HALAVEN® (eribulin) Data in a Variety of Advanced Cancers at ESMO 2018 Congress

News provided by

Eisai Inc.

Oct 09, 2018, 19:30 ET